Dr Amy Watson joins Ethics Talk to discuss how crisis intervention teams can motivate efficiency and equity in tactical responses to 911 calls and what community mental health intervention might look like when we think beyond the limits of law enforcement response.

This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing.

Physicians must resist judging the quality of life of their patients with Down syndrome and learn to listen and see them as individual personalities.

To make good communication choices for their children who are deaf or hard of hearing, hearing parents must develop their understanding of hearing loss.

Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible.

Defining typical appearance as a goal of health service provision is harmful and unnecessary for traits that are stigmatized but neither harmful nor distressing.

Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes.

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.